Article
Determining the origin of genome aberrations improves the positive predictive value of NIPT for 22q11.2 deletion syndrome
9 Jul 2025
Abstract excerpt
Non-invasive prenatal testing (NIPT) has been endorsed by the American College of Medical Genetics and Genomics as the preferred method for screening fetal 22q11.2 deletion syndrome (22q11.2 DS). Maternal genomic aberrations represent a significant source of false positives in NIPT, and there are currently no solutions that effectively address this challenge. We have devised an innovative NIPT bioinformatics...
Topics
Join the communities discussing this publication.
